Legal & General Group
ZOM

Legal & General Group’s Zomedica Corp. ZOM Stock Holding History

Legal & General Group’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-370,118
Closed -$125K – 3780
2022
Q1 		$125K Hold
370,118
– – ﹤0.01% 2812
2021
Q4 		$114K Hold
370,118
– – ﹤0.01% 2884
2021
Q3 		$194K Buy
370,118
+177,858
+93% +$105K ﹤0.01% 2704
2021
Q2 		$160K Buy
+192,260
New +$179K ﹤0.01% 2596
2019
Q3 		– Sell
-5,852
Closed -$1K – 3462
2019
Q2 		$1K Hold
5,852
– – ﹤0.01% 3490
2019
Q1 		$2K Hold
5,852
– – ﹤0.01% 3337
2018
Q4 		$7K Hold
5,852
– – ﹤0.01% 3318
2018
Q3 		$11K Hold
5,852
– – ﹤0.01% 3320
2018
Q2 		$13K Buy
+5,852
New +$11.7K ﹤0.01% 3277

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Legal & General Group's ZOM Position: Q2 2022 in Review

Legal & General Group sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 370,118 shares — an estimated $125K sold.

Legal & General Group first reported a position in ZOM in Q2 2018 and held it in 9 quarters. The position peaked at $194K in Q3 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

  • Legal & General Group reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 370,118 Zomedica Corp. shares in Q2 2022, an estimated $125K.
  • Legal & General Group first reported a position in Zomedica Corp. in Q2 2018 and held it in 9 quarters.
  • Legal & General Group's Zomedica Corp. position peaked at $194K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.